BREAKING
Home » Posts Tagged "BARDA"

Health Security: What is it?, Who are the major players? and Lessons learned from COVID-19 pandemic

By

By Robert Herriman  @bactiman63 US and global health security-what is it, what was the genesis and how prepared are we? These are some of the things I look at in this interview with experts in the field. In...

Anthrax: Single dose intranasal vaccine, NasoShield, Phase 1b clinical trial

By

Altimmune, Inc. announced today dosing of the first patient in the Company’s Phase 1b clinical trial of NasoShield, a single dose intranasal anthrax vaccine candidate. “NasoShield is the only single...

Marburg Virus Disease

Ebola Sudan and Marburg Vaccines: Sabin Vaccine Institute gets $20 million from BARDA for further development

By

The Sabin Vaccine Institute (Sabin) and its partner ReiThera Srl today announced that the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for...

COVID-19: Johnson & Johnson announces selection of a lead vaccine candidate

By

Johnson & Johnson today announced the selection of a lead COVID-19 vaccine candidate from constructs it has been working on since January 2020. They expect to initiate human clinical studies  at...

H5N1 influenza vaccine, AUDENZ™, receives FDA approval

By

Seqirus, a global leader in influenza prevention and pandemic response, today announced that the U.S. Food and Drug Administration (FDA) has approved AUDENZ™ (Influenza A (H5N1) Monovalent Vaccine, Adjuvanted)...

Anthrax antibiotic: Project BioShield funding targets health security threat

By

This week, the U.S. Department of Health and Human Services (HHS) issued the first Project BioShield contract to fund the advanced development needed to support the expanded use of an existing antibiotic...

Pandemic Influenza Vaccine: HHS awards Sanofi Pasteur $226 million contract

By

The U.S. Department of Health and Human Services (HHS) issued a six-year, $226 million contract today to increase capacity to produce recombinant influenza vaccine in the United States. The contract is...

Sepsis diagnostics: HHS to advance development of Cytovale rapid test

By

To advance the development of a test that may be able to diagnose sepsis in less than 10 minutes, the U.S. Department of Health and Human Services (HHS) will partner with Cytovale of San Francisco. Under...

HHS supports development of investigational Ebola treatment

By

An investigational treatment for Ebola virus disease will receive advanced development support from the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness...

Smallpox vaccine enters Phase 3 Trial

By

Bavarian Nordic A/S announced today the initiation of a pivotal Phase 3 trial of the freeze-dried formulation of MVA-BN® smallpox vaccine in 1,110 healthy, vaccinia-naïve subjects. The randomized,...